Skip to main navigation Skip to search Skip to main content

Conflicts of Interest in Psychopharmacology Textbooks

  • University of Massachusetts Boston
  • Tufts University

Research output: Contribution to journalArticlepeer-review

Abstract

While most medical journals require disclosures of industry payments to authors and editors, there is no requirement for textbooks. In this study we evaluated nine well-known psychopharmacology textbooks to identify payments to their writers and editors. Two-thirds of the textbooks had at least one editor or author who received personal payments from one or more pharmaceutical companies, for a total of 11,021,409 USD paid to 11 of 21 editors/authors over a seven-year period. Much of this money was paid to a single author but 24% of the writers received over 75,000 USD each over this time period. There are several psychopharmacology textbooks authored by writers without apparent financial conflicts of interest. Just as with medical journals, medical textbooks should be transparent about payments made to their authors and editors.

Original languageEnglish
Pages (from-to)619-623
Number of pages5
JournalCommunity Mental Health Journal
Volume58
Issue number4
DOIs
StatePublished - May 2022

ASJC Scopus Subject Areas

  • Health(social science)
  • Public Health, Environmental and Occupational Health
  • Psychiatry and Mental health

Keywords

  • Conflict of interest
  • Disclosure
  • Medical education/textbooks
  • Pharmaceutical industry
  • Psychopharmacology

Fingerprint

Dive into the research topics of 'Conflicts of Interest in Psychopharmacology Textbooks'. Together they form a unique fingerprint.

Cite this